Global

Market access: risk sharing and alternative pricing schemes

Shared-risk agreements can represent uncertain rewards for drug makers and payers. What you need to know before entering into one. read...

Bring on the competition!

The marketing team is running around in panic, projections are being reviewed, and sales force strategy abandoned. Why? read...

M’s the word: Get off the phone and check your cholesterol

Why are we willing to pay more for our cellphones than for our health insurance? read...

Forecasting: Patient flow modeling comes of age

Judith Kulich, associate principal, and Emily Jin, manager, at ZS Associates talk to eyeforpharma about how patient flow modeling can inform forecasting read...

Understanding the utility of MPR

Kevin Cast, vice president, Curascript, explains how medication possession ratios (MPR) can improve forecasting and compliance read...

The role of new technologies in enhancing compliance

Peter Mansell reports on how compliance and personal monitoring technologies can help pharma firms better tailor their offerings to different patient groups read...

Q&A: The role of the caregiver in brand loyalty and compliance

Rebecca Joslin, brand associate director for Novartis’ Exelon Patch, on how reaching out to caregivers creates brand loyalty and improves adherenceread...

Compliance and the older patient: How the Web can help

Di Stafford explains how customized digital communication can assist pharma in successfully engaging with older patients read...

How US healthcare reform could change pharma

Healthcare reform has made change in the pharma sector all the more urgent. Is the industry right to take a wait-and-see approach? Andrew Tolve investigates. read...

The future of pharma: managing complex markets

Pharma execs need to discard conventional thinking and prepare their organizations for bursts of sudden, dramatic change, argues Brian Smith. read...
Get Adobe Flash playerPlugin by wpburn.com wordpress themes